View all dosages and compare prices:

Buy Retatrutide — all dosages →
🧬SYNEDICA · Triple agonist GLP-1/GIP/glucagon

Retatrutide 40 mg · SYNEDICA

SYNEDICA · Triple agonist · For weight management

Next-generation triple agonist · 40 mg per pen · Synedica Laboratories · Made in Germany

40 mg
15 500₴
In stock

Ships tomorrow (Fri) · before 19:00

Delivery Sat, Nov 14 · Nova Poshta

💊 Try for 8 000 ₴/mo

Starting dose 2.5 mg · no pen needed · save 20%

Retatrutide 40 mg Synedica (Germany) — triple GLP-1/GIP/glucagon agonist for weight management. 15,500 UAH, 2–8 °C cold-chain, DOZA specialist support.

In short: Retatrutide 40 mg (SYNEDICA)

Price: 15 500 ₴. In stock. Retatrutide is an investigational Eli Lilly molecule (Phase 3; Phase 2 showed −24.2% weight loss at 48 weeks, NEJM 2023). Third-party product, not FDA/EMA-registered. Delivery across Ukraine — Nova Poshta, 1–3 days; Kyiv — courier, 1–2 hours. Cold chain 2–8°C. 24/7 specialist support included in the price. Order on the official DOZA website: doza.clinic.

Active ingredientретатрутид (retatrutide)
Dosage40 mg
Form factorPen
Course~12 weeks (1 kit)
👨‍⚕️

Specialist support included in the price

A personal DOZA specialist guides you throughout the entire course — from first consultation to results.

🧬

Triple agonist — next generation

Retatrutide — a triple GLP-1/GIP/glucagon agonist. Investigational Phase 3 molecule by Eli Lilly. Not approved by FDA/EMA.

🏭

Manufacturer: SYNEDICA

SYNEDICA — a brand of peptide products. Manufacturing meets GMP standards.

Beware of counterfeit Retatrutide

Counterfeit pens may contain unknown substances and cause serious, sometimes irreversible health harm. Do not buy from unverified sources without a verification code.

Why DOZA is the safer choice

We supply only verified SYNEDICA batches from Germany: a unique code on every pen, 2–8°C cold chain, and DOZA specialist support. You can confirm authenticity yourself.

SYNEDICA authenticity verification

Each SYNEDICA pen has a unique verification code. Check authenticity on the manufacturer's official website.

Free consultation

Benefits

  • ✓Triple mechanism of action — only agonist GLP-1 + GIP + glucagon
  • ✓40 mg per pen — 4 full doses of 10 mg each (kit lasts approximately 12 weeks on average)
  • ✓Made in Germany — Synedica Laboratories, Leipzig
  • ✓12 disposable needles 32g 4mm included + instruction manual
  • ✓Isotonic solution, pH 6.5–7.5 — comfortable injection
  • ✓Up to 28.3% weight loss over 80 weeks on the 12 mg/week dose (Phase 3 TRIUMPH-1, topline 2026); Phase 2: up to 24% over 48 weeks (NEJM 2023)
  • ✓Authenticity verification at synedica.io/verify
  • ✓Delivery in thermal box with cooling elements (2–8°C) across Ukraine
  • ✓Free 24/7 DOZA specialist support throughout the entire course

Retatrutide 40 mg (SYNEDICA) — detailed description

Retatrutide 40 mg Synedica — the next generation of incretin agonists for weight management. Unlike semaglutide (Ozempic, Mounjaro — dual or single agonism), Retatrutide simultaneously activates three receptors: GLP-1, GIP and glucagon. In the phase II trial (NEJM, 2023), participants lost up to 24.2% of body weight over 48 weeks — the best result among all injectable weight-loss compounds to date.

About Synedica Laboratories. Synedica is a German brand (manufactured in Berlin) focused on research-grade peptides at pharmaceutical purity. The Synedica 40 mg pen contains a ready-to-use stabilised solution, 200 units (one pen = a titration course 2 → 12 mg over 20–24 weeks per the TRIUMPH protocol).

How to verify Synedica authenticity. Lookalike sites have appeared among sellers of peptide-grade retatrutide in Ukraine (synedica-reta.com, synedica-ua.com) with no physical warehouse and no cold-chain control. Authenticity markers: Synedica Laboratories hologram on the side of the box, QR code → verify.synedica.com (manufacturer's site), serial number starting with "S" (e.g. S-04-24-XXXX), cold thermobox on delivery (no warmer than +8 °C). DOZA sources Retatrutide Synedica directly from the official distributor in Warsaw; on request we send the CoA (Certificate of Analysis) of the specific batch.

Why clients choose Retatrutide at DOZA. Unlike generic online shops, DOZA is a specialised clinic with a supervised programme: a specialist helps set the starting dose (2 mg), build the titration schedule, monitor TSH, liver panel and side effects. Along with the product you receive injection instructions, warnings and access to a supervision chat 24/7.

Delivery. Kyiv — 1 day, all of Ukraine — 1–2 days in a 2–8 °C thermobox with a temperature logger. Payment: 50% prepayment (cold-chain guarantee), 50% on delivery.

Important. Retatrutide is an experimental compound; it is not yet registered as a medicine by the Ministry of Health of Ukraine. It is used in DOZA supervision protocols with the client's informed consent.

How it works — mechanism of action

Retatrutide is the only triple agonist GLP-1 + GIP + glucagon. Acts on three receptors simultaneously:

1. GLP-1 — reduces appetite, slows gastric emptying, regulates glucose levels.

2. GIP — enhances GLP-1 effect and improves fat tissue metabolism.

3. Glucagon — activates lipolysis (fat breakdown) and thermogenesis (calorie burning).

In Phase 3 TRIUMPH-1 (topline 2026), participants on 12 mg lost an average of 28.3% body weight over 80 weeks (efficacy estimand) — the highest published result in the GLP-1 class. Phase 2 (NEJM 2023): up to 24% over 48 weeks.

Dosage

Recommended dosing schedule (synedica.io):

Weeks 1–4: 2.5 mg once weekly

Weeks 5–8: 5 mg once weekly

After 8 weeks: dose may be increased to 7.5 mg or 10 mg as needed

Injection is performed subcutaneously. Do not increase dose until hunger sensation returns.

What's in the kit

Шприц-ручка Synedica Retatrutide з набірним механізмом дозування.

У комплекті:

• 1 ручка = 40 мг ретатрутиду (4 повні дози по 10 мг)

• 12 одноразових голок 32g 4mm

• 1 інструкція (instruction book)

Виробник: Synedica Laboratories, Deutscher Pl. 5b, 04103 Leipzig, Germany.

Країна виробництва: Німеччина.

Composition

Composition of the Synedica 40 mg pen. Active ingredient: Retatrutide (LY3437943) — 40 mg in 2 mL of a stabilised solution (200 units). Excipients: sodium phosphate, phenol (preservative), sodium chloride, glycerol, water for injection.

Retatrutide brand comparison at DOZA.

SYNEDICA 40 mg — Synedica Laboratories, Germany (Berlin). Pre-mixed stabilised pen, 2 mL / 200 units, 20 mg/mL, 32G × 4 needles. Verification: QR → verify.synedica.com. Price at DOZA: 15,500 UAH. Best value, enough for a full titration course 2 → 12 mg.

ALLUVI 40 mg — ALLUVI Healthcare, Switzerland. Pre-mixed pen, 1 mL / 100 units, 40 mg/mL, 32G × 4 needles. Verification: QR → alluvi.com/auth. Price at DOZA: 18,000 UAH. 16% more expensive than Synedica — chosen for principled Swiss pharma or phenol allergy.

PEN PEPTIDE 40 mg — Pen Peptide Inc., USA. MSSPT stabilised pen, 2 mL / 200 units, 20 mg/mL, 31G × 4 needles. Verification: QR → penpeptide.co/verify. Available on request.

What to choose. For most clients we recommend SYNEDICA 40 mg: best value, German quality, enough for a full course. ALLUVI — for principled Swiss pharma. PEN PEPTIDE — US option on request.

Storage

Зберігати в холодильнику при температурі 2–8°C. Не заморожувати.

Зберігати ковпачок на ручці для захисту від світла.

Після першого використання — утилізувати через 12 тижнів.

Не зберігати з приєднаною голкою.

Тримати в недоступному для дітей місці.

Тільки для підшкірного введення.

Тільки для однієї особи.

Клінічні дослідження

Retatrutide (LY3437943 40 mg) — потрійний агоніст GLP-1 + GIP + глюкагон Eli Lilly. Phase 3 TRIUMPH-1/2/3: topline 2026, до −28.3% ваги за 80 тижнів (12 мг). Подача BLA у FDA — план Q1 2027. На /research зібрана доказова база Phase 2/3 та статус trials.

Retatrutide is an investigational drug. Phase 3 TRIUMPH-1/2/3 topline results reported in 2026; US BLA planned Q1 2027. Not approved by FDA, EMA or МОЗ України as of August 2026.

View full клінічні дослідження database →

Titration protocol to 40 mg (retatrutide (triple GLP-1 / GIP / glucagon agonist))

Weeks 1–4
2 mg

Starting dose for all Phase 3 TRIUMPH participants

Weeks 5–8
4 mg

First escalation (target dose for the 4 mg group)

Weeks 9–12
6 mg

Intermediate escalation step

Weeks 13–16
9 mg

Target dose for the 9 mg group

Weeks 17+
12 mg

Maximum TRIUMPH-1 target dose (−28.3% at 80 weeks)

Injection once weekly (per study protocol), subcutaneous (abdomen, thigh or upper arm). Expected weight loss at the 12 mg/week dose: -28.3% over 80 weeks (Phase 3 TRIUMPH-1, topline 2026) (based on clinical studies).

Who is Retatrutide 40 mg for

  • Retatrutide is an investigational drug (Phase 3), not yet approved by the FDA/EMA
  • Triple GLP-1 / GIP / glucagon agonist — a unique mechanism of action
  • For patients for whom single (Ozempic) or dual (Mounjaro) agonists did not deliver enough effect
  • Strictly under medical supervision

Retatrutide 40 mg — compared to other doses

  • Retatrutide 12 mg showed -28.3% weight loss over 80 weeks in Phase 3 TRIUMPH-1 (topline 2026, efficacy estimand); Phase 2 (NEJM 2023): ~24% over 48 weeks
  • In separate trials the numeric result is higher than Mounjaro 15 mg (-22.5%, SURMOUNT-1), but a direct head-to-head trial (NCT06662383) is still ongoing — clinical superiority has not been established
  • Key difference: retatrutide activates the glucagon receptor, increasing energy expenditure
  • Phase 3 results are topline/press-release level — full peer-reviewed publications pending; BLA (US) planned Q1 2027

FAQ about Retatrutide 40 mg (SYNEDICA)

Valentyna Tytorenko

Price of Retatrutide 40 mg Synedica at DOZA — 15,500 UAH for a syringe pen with 200 units (enough for a full titration course 2 → 12 mg over 20–24 weeks). For comparison: ALLUVI 40 mg costs 18,000 UAH (16% more expensive). Thermobox 2–8 °C delivery is included: Kyiv — 1 day, all of Ukraine — 1–2 days. Payment: 50% prepayment (cold-chain guarantee), 50% on delivery.

Valentyna Tytorenko

Diploma-certified endocrinologist, certified dietitian and nutritionist

Ready to start?

Free consultation

DOZA client reviews for Retatrutide 40 mg (SYNEDICA)

★★★★★Olena M.March 2026

Retatrutide 40 mg (SYNEDICA) — noticeable results in just 3 weeks. Cold chain delivery, everything neat. Thank you, DOZA!

★★★★★Dmytro S.April 2026

Ordering Retatrutide 40 mg (SYNEDICA) via DOZA — fast delivery across Ukraine. Consultant helped choose the right dose. Triple agonist works more effectively.

All client results →

Before/after photos · numbers · timelines · reviews

🏆

Buy Retatrutide 40 mg in Ukraine

Buy Retatrutide 40 mg (SYNEDICA) — next-generation triple GLP-1/GIP/glucagon agonist from DOZA. Next-generation triple agonist · 40 mg per pen · Synedica Laboratories · Made in Germany. Dosage 40 mg — for optimal therapeutic effect. Order via DOZA online service, delivery 1–2 days.

Retatrutide 40 mg (SYNEDICA) price — 15 500 ₴.Cold chain delivery in thermal box.

Free DOZA specialist consultation. Available 24/7.

Buy Retatrutide 40 mg (SYNEDICA) in Ukraine — DOZA online service with delivery in 1–2 days. Specialist consultation included.

Information verified

Valentyna Tytorenko

Diploma-certified endocrinologist, certified dietitian and nutritionist

Melnyk Natalia

Gastroenterologist

⚠️ Retatrutide is an investigational product currently undergoing Phase 3 clinical trials. Results may vary. Consult a specialist before starting the program. Retatrutide is currently undergoing large-scale Phase 3 clinical trials (the TRIUMPH program). Final regulatory approval is expected after the completion of trials.